, its pharmaceutically acceptable nontoxic salt, physiologically hydrolyzable ester, hydrate or solvate or its isomers where Q means CH or N; R1 means hydrogen or amino-protective group; R2 and R3 can be similar or different and mean independently hydrogen or hydroxy-protective group; or R2 and R3 together can form cyclic diol-protective group; R4 means hydrogen or carboxyl-protective group; R5,R6 and R7 independently mean hydrogen, amino or substituted amino, hydroxy, alkoxy, C1-4-alkyl, carboxyl or alkoxycarbonyl, or R5 and R6 together with carbon atoms to which they bound can form C3-C7-cycle. EFFECT: improved method of synthesis. 4 cl, 2 tbl"/>
机译:头孢氨苄化合物,其药学上可接受的非氧化盐,可生理水解的酯,具有戊基双键电子构型的异构体,同分异构体和光学异构体及其合成方法
公开/公告号RU2098420C1
专利类型
公开/公告日1997-12-10
原文格式PDF
申请/专利权人 LAKI LTD. (KR);
申请/专利号RU19940032285
发明设计人 DZHAE KHONG JEOKR;CHAN SIK BANGKR;DZHONG CHAN LIMKR;JUNG MIN VUKR;DEOG KHO JANGKR;SE KHO KIMKR;DZHAE KHUN DZHEONKR;MU JONG KIMKR;SAM SIK KIMKR;TAE KHI LIKR;JONG TSU KIMKR;KHUN SEUNG OKHKR;
申请日1994-09-09
分类号C07D501/24;C07D501/04;A61K31/545;C07M7/00;C07M9/00;
国家 RU
入库时间 2022-08-22 02:45:25